Posted on 5/30/18
BrainStorm Cell Therapeutics to Provide Corporate Update
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the Company will present a corporate . . .
Posted on 5/30/18
The Pfizer Foundation Announces $5 Million in Grants
NEW YORK--(BUSINESS WIRE)--The Pfizer Foundation announced today a new $5 million grant commitment to initiatives in low- and middle-income countries that provide family planning access and . . .
Posted on 5/30/18
U.S. Department of Defense Awards $2M Grant to Frequency Therapeutics
WOBURN, Mass. & FARMINGTON, Conn.--(BUSINESS WIRE)--Frequency Therapeutics today announced the receipt of a U.S. Department of Defense Hearing and Balance Research Award grant. The $2 million . . .
Posted on 5/30/18
Daxor Corporation Retains CORE IR as Investor Relations Firm of Record
NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an innovative medical instrumentation and biotechnology company focused on blood volume measurement today . . .
Posted on 5/29/18
Melinta Therapeutics Announces Closing of Underwritten Public Offering
NEW HAVEN, Conn., May 29, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial . . .
Posted on 5/29/18
Ford's Fish Shack Rolls into NYC for Annual Lobster Rumble
The top 25 restaurants in the country face-off at this legendary summer event for a chance to be named “Best Lobster Roll in America”Ford’s Fish Shack . . .
Posted on 5/28/18
Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
THOROFARE, N.J., May 25, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), a developer of rapid health information technologies, announces that it received . . .
Posted on 5/25/18
Atossa Announces $13.4M in Expected Gross Proceeds from Recently Expired Rights Offering
NEW YORK, May 25, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. announced today that the Company’s previously announced rights offering expired on Thursday, May 24, 2018 . . .
Posted on 5/25/18
Campbell Soup: Mmm Mmm Capitulation
With an earnings release that had almost nothing good in it, including an earnings guidance reduction, impairment charges, unforeseen merger integration headwinds, a CEO that abruptly . . .
Posted on 5/25/18
Five WPP Health & Wellness Executives Selected to Judge the 2018 MM&M Awards
WPP Health & Wellness, the leading global marketing communications company, and part of WPP (NYSE: WPP), today announced that five of its leaders have been selected . . .
Posted on 5/25/18
Celgene Corp. Announces Additional $3 Billion Share Repurchase Authorization
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced that the Company's Board of Directors authorized the repurchase of an additional $3 billion of the Company's common . . .
Posted on 5/25/18
Sectra Wins PACS Order at Pediatric Orthopedic Hospital
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will install its enterprise imaging PACS at Texas Scottish Rite Hospital for Children. The Sectra . . .
Posted on 5/25/18
UnitedHealthcare Establishes Long-Term Strategic Partnership with Quest Diagnostics
MINNEAPOLIS & SECAUCUS, N.J.--(BUSINESS WIRE)--UnitedHealthcare and Quest Diagnostics (NYSE: DGX) have established a long-term strategic partnership as the two organizations focus on ways to create more . . .
Posted on 5/25/18
Biopharma Company Kiniksa Goes Public
NEW YORK, May 24, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq:KNSA), a clinical-stage biopharmaceutical company, visited the Nasdaq MarketSite in Times Square today for its . . .
Posted on 5/24/18
ContraVir Pharmaceuticals Announces Reverse Stock Split
EDISON, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the . . .
Posted on 5/24/18
Novartis' Remicade Biosimilar OK'd In Europe
The European Commission approves Novartis (NYSE:NVS) unit Sandoz's Zessly (infliximab), a biosimilar of Johnson & Johnson's (NYSE:JNJ) Remicade.READ FULL ARTICLE HERE
Posted on 5/24/18
Merck (MRK) Investor Presentation - Slideshow
The following slide deck was published by Merck & Co Inc. in conjunction with this event. 130READ FULL ARTICLE HERE
Posted on 5/24/18
Better Buy: AbbVie Inc. vs. Pfizer Inc.
If you're looking to buy a big pharma stock, both AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE)have a lot to offer. AbbVie has been the bigger winner in . . .
Posted on 5/24/18
J&J Loses Second Verdict in Talc Asbestos Cancer Case
Johnson & Johnson (NYSE:JNJ) and its talc suppliers were hit today with a $21.7M jury verdict in JNJ's second trial loss over allegations that its talc-based . . .
Posted on 5/24/18
Regional Cancer Care Associates Recognized for Quality in Value Based Cancer Care
Regional Cancer Care Associates (RCCA) has been recognized with a Blue Distinction® Centers for Cancer Care designation as part of the Blue Distinction Specialty Care program. . . .
Posted on 5/24/18
Melinta Therapeutics Prices Public Offering of Common Stock
NEW HAVEN, Conn., May 23, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial . . .
Posted on 5/22/18
Celgene: Still (Looks) Appealing
Celgene (CELG) has been on my watchlist for a while as its shares continue to lag despite the promise of a rich pipeline, high regard of . . .
Posted on 5/22/18
Johnson & Johnson (JNJ) Presents at UBS Health Care Brokers Conference (Transcript)
Johnson & Johnson (NYSE:JNJ) UBS Health Care Conference May 21, 2018 10:00 AM ETExecutivesMatt Stuckley - IRSandra Peterson - Executive VP & Group Worldwide ChairmanAnalystsVikramjeet Chopra . . .
Posted on 5/22/18
CURE Magazine Names the 2018 Bone Health Champions
CRANBURY, N.J.--(BUSINESS WIRE)--CURE®magazine, the nation’s leading consumer digital and print media enterprise focused entirely on patients with cancer, recognized four nurses as the 2018 Bone Health . . .
Posted on 5/21/18
Melinta Therapeutics Announces Proposed Offering of Common Stock
NEW HAVEN, Conn., May 21, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial . . .

